Fondaparinux versus enoxaparin for prevention of venous.
Morris
Edward
E
D019644:Arthroplasty, Replacement, Hip; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D000077425:Fondaparinux; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D011134:Polysaccharides / Q000009:adverse effects*; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux